Scancell (AgeTech UK) Covid-19
Oncology and Covid. Post-translational modifications, anti-glycan antibodies and cytotoxic T cels for targetting various tumours
Investors
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership